MRNA

#561
Moderna, Inc. - Common Stock
47.1 9 USD
-0.80%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
47.19
47.19
Rango anual
22.29
59.55
Cambio diario
-0.80%
Variación mensual
+2.12%
Variación en los últimos 6 meses
+88.38%
Cambio anual
+78.75%
Cierres anteriores
47.5 7
Open
47.1 9
Mínimo
47.1 9
High
47.1 9
Volumen
365
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Moderna, Inc. - Common Stock

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.

Noticias